Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
1999 Nov 01;1285:981-8. doi: 10.1038/sj.bjp.0702876.
Show Gene links
Show Anatomy links
Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors.
King BF
,
Liu M
,
Pintor J
,
Gualix J
,
Miras-Portugal MT
,
Burnstock G
.
???displayArticle.abstract???
1. The antagonist activity of a series of diinosine polyphosphates (IpnI, where n=3, 4, 5) was assessed against ATP-activated inward currents at rat P2X(1-4) receptors expressed in Xenopus oocytes and studied under voltage-clamp conditions. 2. Diinosine polyphosphates were prepared by the enzymatic degradation of their corresponding diadenosine polyphosphates (e.g., Ap5A into Ip5I) using 5'-adenylic deaminase, and purified using reverse-phase chromatography. 3. Against ATP-responses at rP2X1 receptors, the potency order for antagonism was (pIC50): Ip5I (8.5)>Ip4I (6.3)>Ip3I (>4.5). Ip5I (10-100 nM) caused a concentration-dependent rightwards displacement of the ATP concentration-response curve without reducing the maximum ATP effect. However, the Schild plot was non-linear which indicated Ip5I is not a competitive antagonist. Blockade by micromolar concentrations of Ip5I was not surmountable. Ip4I also behaved as a non-surmountable antagonist. 4. Against ATP-responses at rP2X3 receptors, the potency order for antagonism was (pIC50): Ip4I (6. 0)>Ip5I (5.6)>Ip3I (>4.5). Blockade by Ip4I (pA2, 6.75) and Ip5I (pA2, 6.27) was surmountable at micromolar concentrations. 5. Diinosine polyphosphates failed to inhibit ATP-responses at rP2X2 receptors, whereas agonist responses at rP2X4 were reversibly potentiated by Ip4I and Ip5I. None of the parent diadenosine polyphosphates behave as antagonists at rP2X1 - 4 receptors. 6. Thus, Ip5I acted as a potent and relatively-selective antagonist at the rP2X1 receptor. This dinucleotide pentaphosphate represents a high-affinity antagonist for the P2X1 receptor, at which it acts in a competitive manner at low (</=100 nM) concentrations but has more complex actions at higher (>100 nM) concentrations.
Bo,
A P2X purinoceptor cDNA conferring a novel pharmacological profile.
1995, Pubmed
Bo,
A P2X purinoceptor cDNA conferring a novel pharmacological profile.
1995,
Pubmed
Buell,
P2X1 receptor activation in HL60 cells.
1996,
Pubmed
Chvatchko,
The involvement of an ATP-gated ion channel, P(2X1), in thymocyte apoptosis.
1996,
Pubmed
Collo,
Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels.
1996,
Pubmed
Evans,
Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
1995,
Pubmed
García-Lecea,
P2X2 characteristics of the ATP receptor coupled to [Ca2+]i increases in cultured Purkinje neurons from neonatal rat cerebellum.
1999,
Pubmed
Guranowski,
Conversion of adenosine(5') oligophospho(5') adenosines into inosine(5') oligophospho(5') inosines by non-specific adenylate deaminase from the snail Helix pomatia.
1995,
Pubmed
Hoyle,
Antagonism of P2X receptors in guinea-pig vas deferens by diinosine pentaphosphate.
1997,
Pubmed
Humphreys,
Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues.
1998,
Pubmed
Jacobson,
A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
1998,
Pubmed
,
Xenbase
Khakh,
Estimates of antagonist affinities at P2X purinoceptors in rat vas deferens.
1994,
Pubmed
Kim,
Molecular assembly of the extracellular domain of P2X2, an ATP-gated ion channel.
1997,
Pubmed
King,
Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH.
1996,
Pubmed
,
Xenbase
Kupitz,
A putative ATP-activated Na+ channel involved in sperm-induced fertilization.
1993,
Pubmed
,
Xenbase
Nicke,
P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.
1998,
Pubmed
,
Xenbase
Pintor,
Selectivity and activity of adenine dinucleotides at recombinant P2X2 and P2Y1 purinoceptors.
1996,
Pubmed
,
Xenbase
Pintor,
Presence of dinucleotide and ATP receptors in human cerebrocortical synaptic terminals.
1999,
Pubmed
Pintor,
Diinosine polyphosphates, a group of dinucleotides with antagonistic effects on diadenosine polyphosphate receptor.
1997,
Pubmed
Rae,
Pharmacological properties of P2X3-receptors present in neurones of the rat dorsal root ganglia.
1998,
Pubmed
Ralevic,
Receptors for purines and pyrimidines.
1998,
Pubmed
Soto,
Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors.
1999,
Pubmed
,
Xenbase
Torres,
Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners.
1999,
Pubmed
Townsend-Nicholson,
Molecular cloning, functional characterization and possible cooperativity between the murine P2X4 and P2X4a receptors.
1999,
Pubmed
,
Xenbase
Virginio,
Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors.
1998,
Pubmed
Wildman,
Selectivity of diadenosine polyphosphates for rat P2X receptor subunits.
1999,
Pubmed
,
Xenbase
Wildman,
Modulation of ATP-responses at recombinant rP2X4 receptors by extracellular pH and zinc.
1999,
Pubmed
,
Xenbase
Wildman,
Modulatory activity of extracellular H+ and Zn2+ on ATP-responses at rP2X1 and rP2X3 receptors.
1999,
Pubmed
,
Xenbase
